Gregor Bahrenberg

This inventor holds 46 USPTO granted patents and 9 published patent applications, plus 2 CIPO patents and 23 EPO patents, primarily in Vanilloid Receptor Ligands. Top assignees: Gruenenthal Gmbh, Grunenthal Gmbh, Medifron Dbt Inc.. Active years: 2006-2019.

USPTO Granted Patents = 46 (Patent Applications = 9)

% Patents Active = 10.9

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 23 (Patent Applications = 42)

Average Co-Inventor Count = 5.7

ph-index = 8

Forward Citations = 159(Granted Patents)

Location History:

Aachen-Brand, DE (2011)
Aachen, DE (2006 - 2014)
Monschau-Konzen, DE (2011 - 2017)
Monschau-Kozen, DE (2019)

Company Filing History:

Years Active: 2006-2019

Loading Chart...

Areas of Expertise:

Vanilloid Receptor

KCNQ2/3 Modulators

Pain Relief

Carboxamides

Phenylureas

Amines

Pharmaceutical Compositions

Substituted Compounds

Medicaments

Ligands

Nicotinamides

Urea Derivatives

46 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10265310 - 6-membered cyclic amines or lactames substituted with urea and phenyl (2019-04-23),

2. 9775843 - Treatment and/or prophylaxis of TSPO mediated diseases and/or disorders (2017-10-03),

3. 9771359 - Substituted oxazole- and thiazole-based carboxamide and urea derivatives as vanilloid receptor ligands II (2017-09-26),

4. 9624209 - Substituted phenylureas and phenylamides as vanilloid receptor ligands (2017-04-18),

5. 9284286 - Specific carboxamides as KCNQ2/3 modulators (2016-03-15),

6. 9278103 - Substituted 6-amino-nicotinamides as KCNQ2/3 modulators (2016-03-08),

7. 9248122 - Heteroquinoline-3-carboxamides as KCNQ2/3 modulators (2016-02-02),

8. 9168259 - Substituted 6-amino-nicotinamides as KCNQ2/3 modulators (2015-10-27),

9. 9120756 - Substituted phenylureas and phenylamides as vanilloid receptor ligands (2015-09-01),

10. 9108936 - Substituted 4-aminobenzamides as KCNQ2/3 modulators (2015-08-18),

11. 9073862 - Substituted 2-oxy-quinoline-3-carboxamides as KCNQ2/3 modulators (2015-07-07),

12. 8946204 - Substituted phenylureas and phenylamides as vanilloid receptor ligands (2015-02-03),

13. 8937092 - Aryl or N-heteroaryl substituted methanesulfonamide derivatives as vanilloid receptor ligands (2015-01-20),

14. 8791268 - Vanilloid receptor ligands, pharmaceutical compositions containing them, process for making them, and use thereof for treating pain and other conditions (2014-07-29),

15. 8785474 - Vanilloid receptor ligands, pharmaceutical compositions containing them, process for making them, and use thereof to treat pain and other conditions (2014-07-22),

Title: Gregor Bahrenberg - Innovative Inventor from Monschau-Konzen

Introduction: Gregor Bahrenberg is a renowned inventor hailing from Monschau-Konzen, Germany, known for his groundbreaking contributions to various fields of technology and innovation.

Latest Patents: Gregor Bahrenberg holds several patents in the areas of renewable energy, sustainable materials, and advanced manufacturing processes, showcasing his commitment to creating a more sustainable future.

Career Highlights: With a career spanning over two decades, Gregor Bahrenberg has worked with leading research institutions and companies to develop cutting-edge technologies that have revolutionized industries worldwide.

Collaborations: Throughout his career, Gregor Bahrenberg has collaborated with top engineers, scientists, and designers to bring his innovative ideas to life, resulting in successful products and solutions that have had a lasting impact on society.

Conclusion: Gregor Bahrenberg's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a visionary inventor, shaping the future of technology and inspiring the next generation of innovators.